Literature DB >> 10918580

Differential transcriptional regulation of the monocyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells: the role of the chromatin structure and AP-1 composition.

P Finzer1, U Soto, H Delius, A Patzelt, J F Coy, A Poustka, H zur Hausen, F Rösl.   

Abstract

The expression of the monocyte-chemoattractant-protein-1 (MCP-1) is closely linked with a non-tumorigenic phenotype in somatic cell hybrids made between the human papillomavirus type 18 (HPV 18) positive cervical carcinoma cell line HeLa and normal human fibroblasts. In contrast, MCP-1 transcription is absent in tumorigenic segregants derived from the same hybrids or in parental HeLa cells. Selectivity of MCP-1 transcription, which is regulated at the level of initiation of transcription, is mainly based on differences in the location and extension of DNAse I-hypersensitive regions (DHSR) at both ends of the gene. While TNF-alpha only moderately increases the sensitivity of pre-existing 5'-DHSRs, a 3'-end DHSR became strongly induced exclusively in non-malignant hybrids. DNA sequencing showed that the 3'-DHSR coincides with an additional AP-1 site located approximately 600 bp downstream of the polyadenylation site. Analyses of AP-1 composition revealed that MCP-1 is only expressed in those cells where jun-family members were mainly heterodimerized with the fos-related protein fra-1. In contrast, in tumorigenic cells the 1: 1 ratio between jun and fra-1 is disturbed and the MCP-1 gene is no longer expressed. Hence, alterations in the heterodimerization pattern of AP-1 and its selective accessibility to opened chromatin may represent a novel regulatory pathway in the regulation of chemokines in malignant and non-malignant HPV-positive cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918580     DOI: 10.1038/sj.onc.1203643

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells.

Authors:  Anastasia Bachmann; Brigitte Hanke; Rainer Zawatzky; Ubaldo Soto; Jan van Riggelen; Harald zur Hausen; Frank Rösl
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Poly(ADP-ribose) polymerase 1 activation links ischemic acute kidney injury to interstitial fibrosis.

Authors:  Sang Pil Yoon; Jinu Kim
Journal:  J Physiol Sci       Date:  2014-11-12       Impact factor: 2.781

3.  Regulation of MCP-1 chemokine transcription by p53.

Authors:  Katrin Hacke; Bladimiro Rincon-Orozco; Gilles Buchwalter; Simone Y Siehler; Bohdan Wasylyk; Lisa Wiesmüller; Frank Rösl
Journal:  Mol Cancer       Date:  2010-04-20       Impact factor: 27.401

4.  c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene.

Authors:  Sabine Wolter; Anneke Doerrie; Axel Weber; Heike Schneider; Elke Hoffmann; Juliane von der Ohe; Latifa Bakiri; Erwin F Wagner; Klaus Resch; Michael Kracht
Journal:  Mol Cell Biol       Date:  2008-04-28       Impact factor: 4.272

5.  Protein kinase C-δ (PKCδ) regulates proinflammatory chemokine expression through cytosolic interaction with the NF-κB subunit p65 in vascular smooth muscle cells.

Authors:  Jun Ren; Qiwei Wang; Stephanie Morgan; Yi Si; Aarthi Ravichander; Changlin Dou; K Craig Kent; Bo Liu
Journal:  J Biol Chem       Date:  2014-02-11       Impact factor: 5.157

6.  Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells.

Authors:  'Matladi N Ndlovu; Carine Van Lint; Karlien Van Wesemael; Pieter Callebert; Dany Chalbos; Guy Haegeman; Wim Vanden Berghe
Journal:  Mol Cell Biol       Date:  2009-08-17       Impact factor: 4.272

7.  Induction of the gene encoding macrophage chemoattractant protein 1 by Orientia tsutsugamushi in human endothelial cells involves activation of transcription factor activator protein 1.

Authors:  Nam-Hyuk Cho; Seung-Yong Seong; Myung-Sook Huh; Na-Hyun Kim; Myung-sik Choi; Ik-sang Kim
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.

Authors:  Ellora Sen; Samina Alam; Craig Meyers
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Prostaglandin F2α regulation of mRNA for activating protein 1 transcriptional factors in porcine corpora lutea (CL): lack of induction of JUN and JUND in CL without luteolytic capacity.

Authors:  F J Diaz; W Luo; M C Wiltbank
Journal:  Domest Anim Endocrinol       Date:  2012-10-08       Impact factor: 2.290

10.  The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity.

Authors:  Maria Alice G Gonçalves; Edson G Soares; Eduardo A Donadi
Journal:  Infect Agent Cancer       Date:  2009-08-18       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.